Home

PB Ratio of Senores Pharmaceuticals Ltd

Image

Senores Pharmaceuticals Ltd

NSE: SENORES

PB Ratio

3.9

Last updated on: Aug 01, 2025

Key Highlights

  • The latest PB Ratio of Senores Pharmaceuticals Ltd is 3.9.
  • The PB ratio of the Senores Pharmaceuticals Ltd is above 3 which indicates that the stock is overvalued but this is common in high-growing sectors.
  • The P/B Ratio of Senores Pharmaceuticals Ltd changed from 0 on March 2022 to 0 on March 2024 . This represents a CAGR of 0.0% over 3 years.

Historical P/B Ratio of Senores Pharmaceuticals Ltd

No data available

Company Fundamentals for Senores Pharmaceuticals Ltd

Market Cap

3,069 Cr

EPS

14.7

P/E Ratio (TTM)

45.4

P/B Ratio (TTM)

3.9

Day’s High

693.8

Day’s Low

663.35

DTE

0.4

ROE

7.4

52 Week High

718.2

52 Week Low

440.0

ROCE

8.4

Market Price of Senores Pharmaceuticals Ltd

1M

1Y

3Y

5Y

Monitoring Senores Pharmaceuticals Ltd share price can help you stay informed about potential market shifts and opportunities. *All values are in Rupees.

Last Ten Days Market Price

Date
leftPrice (₹)right
01 Aug 2025666.55
31 Jul 2025688.6
30 Jul 2025695.45
29 Jul 2025704.5
28 Jul 2025642.95
25 Jul 2025668.1
24 Jul 2025678.65
23 Jul 2025609.75
22 Jul 2025616.35
21 Jul 2025608.65

SWOT Analysis

Strength

0

che

Weakness

0

che

Opportunity

0

che

Threats

0

che

BlinkX Score for Senores Pharmaceuticals Ltd

Asset Value vs Market Value of Senores Pharmaceuticals Ltd

Market Value

0

Asset Value

0

* All values are in ₹ crores

Competitive Comparison of P/B Ratio

PB Ratio of Senores Pharmaceuticals Ltd Explained

3069

Market cap

171

Book Value per Share

3.9X

PB Ratio

Historical Market Cap of Senores Pharmaceuticals Ltd

Market Cap

No data available

* All values are in crore

Historical Revenue, EBITDA and Net Profit of Senores Pharmaceuticals Ltd

Revenue

EBITDA

Net Profit

No data available

* All values are in crore

Dividend Payout Over Time

No data available

Senores Pharmaceuticals Ltd News Hub

Senores Pharma spurts as PAT jumps to Rs 16 cr in Q3 FY25

Profit before tax stood at Rs 20.48 crore in the December 2024 quarter, up 99.61% from Rs 10.26 cror

Read more

23 Jan 25

Senores Pharma gets final approval for Metoprolol Tartrate and Hydrochlorothiazide tablets

Metoprolol Tartrate and Hydrochlorothiazide Tablet is the combination tablet of metoprolol tartrate,

Read more

10 Jan 25

Senores Pharmaceuticals to hold board meeting

Senores Pharmaceuticals will hold a meeting of the Board of Directors of the Company on 15 May 2025.

Read more

10 May 25

Senores Pharmaceuticals IPO subscribed 93.41 times

The initial public offer (IPO) of Senores Pharmaceuticals received bids for 79,72,30,918 shares as a

Read more

24 Dec 24

Document

Annual Reports

N/A

dropdown
download

Credit Ratings

N/A

dropdown
download

Concalls

Data not available

FAQs for PB Ratio of Senores Pharmaceuticals Ltd

What is the PB ratio of Senores Pharmaceuticals Ltd?

The current PB ratio of Senores Pharmaceuticals Ltd is 3.9. The Price-to-Book value (P/B) ratio compares a company's current share price to its book value per share. It helps assess whether a stock is overvalued or undervalued relative to its net asset value.

What is the ideal PB ratio to buy Senores Pharmaceuticals Ltd stocks?

An ideal PB ratio varies by industry; however, a PB ratio below 1.0 may indicate a good buying opportunity for Senores Pharmaceuticals Ltd. Some investors and financial analysts may also consider any value under 3.0 as a good PB ratio.

How is the PB Ratio of Senores Pharmaceuticals Ltd calculated?

The PB ratio of Senores Pharmaceuticals Ltd is calculated by dividing the current share price by the book value per share. The book value per share is determined by dividing the company’s total net assets (assets minus liabilities) by the number of outstanding shares. This ratio helps evaluate how the market values the company's assets.

What does a high PB Ratio mean for Senores Pharmaceuticals Ltd?

A high PB ratio suggests that Senores Pharmaceuticals Ltd’s stock may be overvalued relative to its book value or that investors expect high growth.

What does a low PB Ratio indicate for Senores Pharmaceuticals Ltd?

A low PB ratio of Senores Pharmaceuticals Ltd may indicate that the stock is undervalued or it is facing financial difficulties.

Can Senores Pharmaceuticals Ltd PB Ratio change over time?

Yes, the PB ratio of Senores Pharmaceuticals Ltd can change over time due to fluctuations in the company’s stock price and changes in its book value.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions

Join the

Future of Trading

with BlinkX

#ItsATraderThing

Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions